Patient-related risk factors appear to be the primary driver of readmissions in hospitals serving a higher proportion of minority patients, according to a study published online yesterday by the journal Surgery. The researchers examined outcomes and patient factors in more than 168,000 colorectal surgery patients treated in 374 California hospitals from 2004-2011, including 47 hospitals with a high percentage of minority patients (63%) compared with the other hospitals (17%). They found that patient factors (such as race, low income and insurance status) accounted for up to 65% of the increased odds for readmission at the minority-serving hospitals, while hospital-level factors (such as procedure volume and type) accounted for up to 40%. The Centers for Medicare & Medicaid Services’ Hospital Readmissions Reduction Program penalizes hospitals for higher-than-expected readmission rates for certain conditions, the authors note. “These findings suggest that CMS should account for patient socio-economic factors when they compare readmission rates,” said Waddah Al-Refaie, M.D., the study’s senior investigator and chief of surgical oncology at MedStar Georgetown University Hospital in Washington, D.C.

Related News Articles

Headline
In clinical trials involving 220,000 patients at 59 HCA Healthcare hospitals, algorithm-driven computerized alerts helped clinicians better identify the…
Headline
Commenting April 12 on a proposed rule to strengthen oversight of accrediting organizations, AHA told the Centers for Medicare & Medicaid Services it…
Blog
Since 2018, Black Maternal Health Week has been a national observance from April 11–17. This annual observance was created by the Black Mamas Matter Alliance…
Headline
The Food and Drug Administration’s proposal to regulate laboratory developed tests would undermine innovation and reduce access to effective and appropriate…
Chairperson's File
 Fostering a culture of innovation and safety that prioritizes communication and teamwork to deliver safe, world-class care to patients and also protects…
Headline
The Food and Drug Administration’s proposal to regulate laboratory developed tests would undermine innovation and reduce access to effective and appropriate…